Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs Twilio Inc (TWLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs Twilio Inc — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.33 (market cap $2.27B), while Twilio Inc trades at $277.18 (market cap $42.35B). The key difference: Twilio Inc is far larger — about 18.7× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Twilio Inc is trading nearer its 52-week high, SELLAS Life Sciences Group Inc. Common Stock nearer its low. Which is the better fit depends on your goals.
| SLS | TWLO | |
|---|---|---|
Market Cap | $2.27B | $42.35B |
Volume | 4,179,659 | 1,862,642 |
Sector | Health | Technology |
52-Week High | $15.46 | $301.27 |
52-Week Low | $1.39 | $106.23 |
Enterprise Value | $2.14B | $40.76B |
Typical Hold Time | — | 56 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Twilio (TWLO) trades at $273.00, down 2.64% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company has beaten EPS estimates for three consecutive quarters, with Q3 2026 results pending. Revenue growth accelerated to $5.07 billion in 2025, turning net income positive at $33.83 million after prior losses. Recent inclusion in the S&P 500 index highlights institutional recognition, while analyst consensus remains strongly bullish with 76.9% buy ratings.
Outlook is positive given earnings momentum and S&P 500 inclusion, but high valuation multiples (P/E 37.71, EV/EBITDA 80.78) pose risks if growth slows. Competitive pressures in customer engagement software and potential volatility from AI-driven sentiment shifts require monitoring. The stock trades above the consensus price target of $254.65, suggesting near-term consolidation may precede further gains if execution continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About Twilio Inc
Twilio Inc. is a cloud-based communication platform-as-a-service company offering communication building blocks that allow for a fully customized customer engagement experience spanning voice, video, chat, and SMS messaging. It does this through various application programming interfaces, or APIs, and prebuilt solution applications aimed at improving customer engagement. The company leverages its Super Network, a global network of carrier relationships, to facilitate high-speed, cost-effective communication.
Read more on TWLO →
